Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2007

Nov 20, 2007

34975_dirs_2007-11-20_0055bfff-b508-487d-955b-0197c5a7cc31.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2007-11-16

Reporting Person: HSO LIMITED PARTNERSHIP (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-11-16 Common Stock P 6210 $3.8999 Acquired 3467718 Direct
2007-11-16 Common Stock P 7612 $3.8988 Acquired 3475330 Direct
2007-11-16 Common Stock P 4567 $3.9063 Acquired 3479897 Direct
2007-11-19 Common Stock P 5043 $3.741 Acquired 3484940 Direct

Footnotes

F1: This amendment is being filed in order amend four line-items by correcting (a) a typographical error included in one
line-item as to the number of shares purchased and (b) making corresponding revisions to the total amounts listed in column
5 of each of the four line-items based on such corrected number of shares purchased.

F2: The reporting person's purchase of HBIO common stock reported herein was matchable under Section 16(b) of the Securities
Exchange Act of 1934, as amended, to the extent of 100 shares, with the reporting person's sale of 100 shares of HBIO common
stock on September 25, 2007 (the "Sale"). The reporting person has agreed to pay to HBIO the full amount of the profit
realized in connection with the short-swing transactions, less transaction costs, and less amounts previously paid to HBIO
by the reporting person in connection with the Sale and a previously disclosed transaction matchable against the Sale.